-
1
-
-
0016434332
-
Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders
-
Wands JR, Chura CM, Roll FJ, Maddrey WC. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology 1975; 68:105-12.
-
(1975)
Gastroenterology
, vol.68
, pp. 105-112
-
-
Wands, J.R.1
Chura, C.M.2
Roll, F.J.3
Maddrey, W.C.4
-
2
-
-
0016698251
-
Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy
-
Galbraith RM, Eddleston AL, Williams R, Zuckerman AJ. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet 1975; 2:528-30.
-
(1975)
Lancet
, vol.2
, pp. 528-530
-
-
Galbraith, R.M.1
Eddleston, A.L.2
Williams, R.3
Zuckerman, A.J.4
-
3
-
-
0019522817
-
Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis
-
Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981; 94:744-8.
-
(1981)
Ann Intern Med
, vol.94
, pp. 744-748
-
-
Hoofnagle, J.H.1
Dusheiko, G.M.2
Seeff, L.B.3
Jones, E.A.4
Waggoner, J.G.5
Bales, Z.B.6
-
4
-
-
0020079497
-
Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
-
Hoofnagle JH, Dusheiko GM, Schafer DF, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96:447-9.
-
(1982)
Ann Intern Med
, vol.96
, pp. 447-449
-
-
Hoofnagle, J.H.1
Dusheiko, G.M.2
Schafer, D.F.3
-
5
-
-
0026088152
-
Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: Report of a prospective study
-
Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy: report of a prospective study. Gastroenterology 1991; 100:182-8.
-
(1991)
Gastroenterology
, vol.100
, pp. 182-188
-
-
Lok, A.S.1
Liang, R.H.2
Chiu, E.K.3
Wong, K.L.4
Chan, T.K.5
Todd, D.6
-
6
-
-
10744222282
-
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy
-
Lau GK, Yiu HH, Fong DY, et al. Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy. Gastroenterology 2003; 125:1742-9.
-
(2003)
Gastroenterology
, vol.125
, pp. 1742-1749
-
-
Lau, G.K.1
Yiu, H.H.2
Fong, D.Y.3
-
7
-
-
2342580717
-
Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy
-
Leaw SJ, Yen CJ, Huang WT, Chen TY, Su WC, Tsao CJ. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy. Ann Hematol 2004; 83:270-5.
-
(2004)
Ann Hematol
, vol.83
, pp. 270-275
-
-
Leaw, S.J.1
Yen, C.J.2
Huang, W.T.3
Chen, T.Y.4
Su, W.C.5
Tsao, C.J.6
-
8
-
-
1542503712
-
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
-
Yeo W, Chan PK, Ho WM, et al. Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy. J Clin Oncol 2004; 22:927-34.
-
(2004)
J Clin Oncol
, vol.22
, pp. 927-934
-
-
Yeo, W.1
Chan, P.K.2
Ho, W.M.3
-
9
-
-
12344315888
-
Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients
-
Yeo W, Ho WM, Hui P, et al. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients. Breast Cancer Res Treat 2004; 88:209-15.
-
(2004)
Breast Cancer Res Treat
, vol.88
, pp. 209-215
-
-
Yeo, W.1
Ho, W.M.2
Hui, P.3
-
11
-
-
0026782953
-
Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen
-
Kuhns M, McNamara A, Mason A, Campbell C, Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatitis B after sustained loss of surface antigen. Gastroenterology 1992; 103:1649-56.
-
(1992)
Gastroenterology
, vol.103
, pp. 1649-1656
-
-
Kuhns, M.1
McNamara, A.2
Mason, A.3
Campbell, C.4
Perrillo, R.5
-
12
-
-
0027375850
-
Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B
-
Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993; 18:1313-8.
-
(1993)
Hepatology
, vol.18
, pp. 1313-1318
-
-
Fong, T.L.1
Di Bisceglie, A.M.2
Gerber, M.A.3
Waggoner, J.G.4
Hoofnagle, J.H.5
-
14
-
-
0345195966
-
Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: A retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc
-
Dhedin N, Douvin C, Kuentz M, et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 1998; 66:616-9.
-
(1998)
Transplantation
, vol.66
, pp. 616-619
-
-
Dhedin, N.1
Douvin, C.2
Kuentz, M.3
-
15
-
-
0036669971
-
Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease
-
Seth P, Alrajhi AA, Kagevi I, et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 30:189-94.
-
(2002)
Bone Marrow Transplant
, vol.30
, pp. 189-194
-
-
Seth, P.1
Alrajhi, A.A.2
Kagevi, I.3
-
16
-
-
27444444509
-
Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: Case report and review of the literature
-
Kempinska A, Kwak EJ, Angel JB. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin Infect Dis 2005; 41:1277-82.
-
(2005)
Clin Infect Dis
, vol.41
, pp. 1277-1282
-
-
Kempinska, A.1
Kwak, E.J.2
Angel, J.B.3
-
17
-
-
0035804282
-
Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab
-
Dervite I, Hober D, Morel P. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med 2001; 344:68-9.
-
(2001)
N Engl J Med
, vol.344
, pp. 68-69
-
-
Dervite, I.1
Hober, D.2
Morel, P.3
-
18
-
-
0042941863
-
Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy
-
Westhoff TH, Jochimsen F, Schmittel A, et al. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 2003; 102:1930.
-
(2003)
Blood
, vol.102
, pp. 1930
-
-
Westhoff, T.H.1
Jochimsen, F.2
Schmittel, A.3
-
19
-
-
24044431565
-
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb
-
Sarrecchia C, Cappelli A, Aiello P. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother 2005; 11:189-91.
-
(2005)
J Infect Chemother
, vol.11
, pp. 189-191
-
-
Sarrecchia, C.1
Cappelli, A.2
Aiello, P.3
-
20
-
-
22144436318
-
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations
-
Law JK, Ho JK, Hoskins PJ, Erb SR, Steinbrecher UP, Yoshida EM. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma 2005; 46:1085-9.
-
(2005)
Leuk Lymphoma
, vol.46
, pp. 1085-1089
-
-
Law, J.K.1
Ho, J.K.2
Hoskins, P.J.3
Erb, S.R.4
Steinbrecher, U.P.5
Yoshida, E.M.6
-
21
-
-
33745838900
-
Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab
-
Sera T, Hiasa Y, Michitaka K, et al. Anti-HBs-positive liver failure due to hepatitis B virus reactivation induced by rituximab. Intern Med 2006; 45:721-4.
-
(2006)
Intern Med
, vol.45
, pp. 721-724
-
-
Sera, T.1
Hiasa, Y.2
Michitaka, K.3
-
22
-
-
33746335161
-
Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region
-
Kitano K, Kobayashi H, Hanamura M, et al. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region. Eur J Haematol 2006; 77:255-8.
-
(2006)
Eur J Haematol
, vol.77
, pp. 255-258
-
-
Kitano, K.1
Kobayashi, H.2
Hanamura, M.3
-
23
-
-
33745753570
-
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy
-
Hui CK, Cheung WW, Zhang HY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 2006; 131:59-68.
-
(2006)
Gastroenterology
, vol.131
, pp. 59-68
-
-
Hui, C.K.1
Cheung, W.W.2
Zhang, H.Y.3
-
24
-
-
0028337236
-
Transmission of hepatitis C in an isolated area in Japan: Community-acquired infection. The South Kiso Hepatitis Study Group
-
Kiyosawa K, Tanaka E, Sodeyama T, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology 1994; 106:1596-602.
-
(1994)
Gastroenterology
, vol.106
, pp. 1596-1602
-
-
Kiyosawa, K.1
Tanaka, E.2
Sodeyama, T.3
-
25
-
-
33746349885
-
Fatal HBV reactivation in a subject with anti-HBs and anti-HBc
-
Umemura T, Kiyosawa K. Fatal HBV reactivation in a subject with anti-HBs and anti-HBc. Intern Med 2006; 45:747-8.
-
(2006)
Intern Med
, vol.45
, pp. 747-748
-
-
Umemura, T.1
Kiyosawa, K.2
-
26
-
-
10744231622
-
Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated apalstic anemia, or acute and chronic non-A-E hepatitis
-
Umemura T, Tanaka E, Ostapowicz G, et al. Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated apalstic anemia, or acute and chronic non-A-E hepatitis. J Infect Dis 2003; 188:1545-52.
-
(2003)
J Infect Dis
, vol.188
, pp. 1545-1552
-
-
Umemura, T.1
Tanaka, E.2
Ostapowicz, G.3
-
27
-
-
33750356541
-
Classification of hepatitis B virus genotypes by the PCR-invader method with genotype-specific probes
-
Tadokoro K, Kobayashi M, Yamaguchi T, et al. Classification of hepatitis B virus genotypes by the PCR-invader method with genotype-specific probes. J Virol Methods 2006; 138:30-9.
-
(2006)
J Virol Methods
, vol.138
, pp. 30-39
-
-
Tadokoro, K.1
Kobayashi, M.2
Yamaguchi, T.3
-
28
-
-
33746339209
-
A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: An update
-
Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006; 4:936-62.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 936-962
-
-
Keeffe, E.B.1
Dieterich, D.T.2
Han, S.H.3
-
29
-
-
33751214224
-
-
Liu CJ, Kao JH, Chen DS. Kinetics of hepatitis B virus reactivation after chemotherapy: more questions than answers. Gastroenterology 2006; 131:1656 (author reply: Gastroenterology 2006; 131:1657).
-
Liu CJ, Kao JH, Chen DS. Kinetics of hepatitis B virus reactivation after chemotherapy: more questions than answers. Gastroenterology 2006; 131:1656 (author reply: Gastroenterology 2006; 131:1657).
-
-
-
-
30
-
-
33747076653
-
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection
-
Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006; 44:326-34.
-
(2006)
Hepatology
, vol.44
, pp. 326-334
-
-
Ozasa, A.1
Tanaka, Y.2
Orito, E.3
-
31
-
-
0035196637
-
A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group
-
Orito E, Mizokami M, Sakugawa H, et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 2001; 33:218-23.
-
(2001)
Hepatology
, vol.33
, pp. 218-223
-
-
Orito, E.1
Mizokami, M.2
Sakugawa, H.3
|